NZ740663A - Treatment of diabetic peripheral neuropathy using placental cells - Google Patents

Treatment of diabetic peripheral neuropathy using placental cells

Info

Publication number
NZ740663A
NZ740663A NZ740663A NZ74066316A NZ740663A NZ 740663 A NZ740663 A NZ 740663A NZ 740663 A NZ740663 A NZ 740663A NZ 74066316 A NZ74066316 A NZ 74066316A NZ 740663 A NZ740663 A NZ 740663A
Authority
NZ
New Zealand
Prior art keywords
subject
composition
treatment
peripheral neuropathy
diabetic peripheral
Prior art date
Application number
NZ740663A
Other languages
English (en)
Inventor
Steven Fischkoff
Denesh Chitkara
Original Assignee
Celularity Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celularity Inc filed Critical Celularity Inc
Publication of NZ740663A publication Critical patent/NZ740663A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48Reproductive organs
    • A61K35/50Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NZ740663A 2015-09-15 2016-09-14 Treatment of diabetic peripheral neuropathy using placental cells NZ740663A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562218885P 2015-09-15 2015-09-15
PCT/US2016/051571 WO2017048741A1 (en) 2015-09-15 2016-09-14 Treatment of diabetic peripheral neuropathy using placental cells

Publications (1)

Publication Number Publication Date
NZ740663A true NZ740663A (en) 2022-12-23

Family

ID=58289824

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ740663A NZ740663A (en) 2015-09-15 2016-09-14 Treatment of diabetic peripheral neuropathy using placental cells

Country Status (17)

Country Link
US (2) US20180264048A1 (https=)
EP (2) EP3349771A4 (https=)
JP (3) JP2018529683A (https=)
KR (1) KR20180051631A (https=)
CN (1) CN108367028A (https=)
AU (1) AU2016323120A1 (https=)
BR (1) BR112018005014B1 (https=)
CA (1) CA2998759A1 (https=)
CO (1) CO2018003759A2 (https=)
EA (1) EA201890720A1 (https=)
IL (2) IL281185B2 (https=)
MX (1) MX2018003275A (https=)
MY (1) MY203748A (https=)
NZ (1) NZ740663A (https=)
SG (1) SG10201912572VA (https=)
WO (1) WO2017048741A1 (https=)
ZA (1) ZA201801708B (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118284725A (zh) 2021-11-10 2024-07-02 三菱化学株式会社 碳纤维、碳纤维束和碳纤维束的制造方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5190556A (en) 1991-03-19 1993-03-02 O.B. Tech, Inc. Cord cutter sampler
US5372581A (en) 1993-07-21 1994-12-13 Minneapolis Children's Services Corporation Method and apparatus for placental blood collection
US6384105B1 (en) 1999-04-16 2002-05-07 William Marsh Rice University Poly(Propylene Fumarate) cross linked with Poly(Ethylene Glycol)
US6355699B1 (en) 1999-06-30 2002-03-12 Ethicon, Inc. Process for manufacturing biomedical foams
DK1349918T3 (da) 2000-12-06 2014-11-10 Anthrogenesis Corp Fremgangsmåde til indsamling af stamceller fra moderkagen
US7311905B2 (en) 2002-02-13 2007-12-25 Anthrogenesis Corporation Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
EP3246396B1 (en) 2001-02-14 2020-01-29 Celularity, Inc. Renovation and repopulation of decellularized tissues and cadaveric organs by stem cells
EP2316919B1 (en) 2001-02-14 2015-10-07 Anthrogenesis Corporation Post-partum mammalian placenta, its use and placental stem cells therefrom
US20030187515A1 (en) 2002-03-26 2003-10-02 Hariri Robert J. Collagen biofabric and methods of preparing and using the collagen biofabric
US20040161419A1 (en) * 2002-04-19 2004-08-19 Strom Stephen C. Placental stem cells and uses thereof
US7255729B2 (en) 2003-05-30 2007-08-14 Noritake Co., Limited Porous cylindrical-body module, structure for supporting porous cylindrical bodies, and method for fastening a supporting member
US7147626B2 (en) 2004-09-23 2006-12-12 Celgene Corporation Cord blood and placenta collection kit
PT2471904T (pt) 2005-12-29 2019-02-25 Celularity Inc População de células estaminais placentárias
CA2633980A1 (en) 2005-12-29 2007-07-12 Anthrogenesis Corporation Improved composition for collecting and preserving placental stem cells and methods of using the composition
US20090018151A1 (en) * 2007-02-23 2009-01-15 Ezekiel Fink Topical Treatment of Peripheral diabetic complications
LT2556145T (lt) * 2010-04-07 2016-11-10 Anthrogenesis Corporation Angiogenezė naudojant placentos kamienines ląsteles
JP6104896B2 (ja) * 2011-06-01 2017-03-29 アントフロゲネシス コーポレーション 胎盤幹細胞を使用する疼痛の治療

Also Published As

Publication number Publication date
EP3957315A1 (en) 2022-02-23
IL258048A (en) 2018-05-31
SG10201912572VA (en) 2020-02-27
CA2998759A1 (en) 2017-03-23
IL281185B1 (en) 2024-01-01
JP2021183635A (ja) 2021-12-02
IL281185B2 (en) 2024-05-01
EA201890720A1 (ru) 2018-09-28
BR112018005014B1 (pt) 2022-03-22
US20220072063A1 (en) 2022-03-10
JP2018529683A (ja) 2018-10-11
JP2023171769A (ja) 2023-12-05
MX2018003275A (es) 2018-05-16
EP3349771A1 (en) 2018-07-25
KR20180051631A (ko) 2018-05-16
WO2017048741A1 (en) 2017-03-23
EP3349771A4 (en) 2019-04-24
IL281185A (en) 2021-04-29
CN108367028A (zh) 2018-08-03
CO2018003759A2 (es) 2018-12-14
BR112018005014A2 (https=) 2018-10-02
ZA201801708B (en) 2019-01-30
US20180264048A1 (en) 2018-09-20
AU2016323120A1 (en) 2018-04-12
MY203748A (en) 2024-07-17

Similar Documents

Publication Publication Date Title
Kim et al. Combined clinic-home approach for upper limb robotic therapy after stroke: a pilot study
AU2018240515A1 (en) Nucleic acids encoding CRISPR-associated proteins and uses thereof
BRPI0411856A (pt) composições e métodos para o aumento da atividade de telomerase
EP3818991A3 (en) Compositions and methods for treating diseases
BR112012019176A2 (pt) peça de vestuário, em particular uma peça de compressão para uso medicinal.
Standley et al. In vitro modeling of repetitive motion strain and manual medicine treatments: potential roles for pro-and anti-inflammatory cytokines
BRPI0919020B8 (pt) uso de células de linhagem monocitária enriquecidas para tratar isquemia e para tratar angina pectoris
MX380480B (es) Composiciones farmacéuticas que contienen insulina.
BR112013005673A2 (pt) uso de lipase de ácido lisossomal para tratamento de deficiência de lipase de ácido lisossomal em pacientes
EA201290357A1 (ru) Предмет одежды одноразового использования
DOP2023000261A (es) Derivados de 3–(1–oxoisoindolin–2–il)piperidina–2,6–diona y sus usos médicos
MX2021004185A (es) Polipeptidos analogos de la amilina humana y sus metodos de uso.
AR131560A1 (es) Métodos para tratar pots mediante el uso de antagonistas de fcrn
EA200970345A1 (ru) Лечение гипербилирубинемии новорожденных с использованием низких дозировок станнсопорфина
CO2023013486A2 (es) Derivados de pirazolopiridina y sus usos
Kim et al. Miniscalpel needle therapy with integrative Korean medical treatment for carpal tunnel or tarsal tunnel syndrome: case series of three patients
NZ740663A (en) Treatment of diabetic peripheral neuropathy using placental cells
JOP20230173A1 (ar) أشطر إطالة العمر-النصفي وطرق استخدامها
BR112022000954A2 (pt) Método para a produção de uma composição enzimática compreendendo uma endopeptidase recombinante
Soares et al. Complex decongestant therapy with use of alternative material to reduce and control lymphedema in patients with endemic area of filariasis: a clinical trial
MX2021010088A (es) Composicion topica para mejorar la curacion de las dolencias oculares.
PT1585513E (pt) Utilizacao de acido docosa-hexaenoico como substancia activa para o tratamento de lipodistrofia
Loghmani et al. Instrument-assisted soft tissue mobilization in healthy young adult males mobilizes tissue-resident mesenchymal stem cells into circulation
CN203762339U (zh) 一种无缝式护肤保健仿真人造皮肤穿戴物
PA8806001A1 (es) Nuevo uso medico de las sales de propionato de 3-(2,2,2-trimetilhidrazinio) en el tratamiento de la enfermedad cardíaca isquémica

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 14 SEP 2024 BY COMPUTER PACKAGES INC

Effective date: 20230817

LAPS Patent lapsed